Application Effect Analysis of Bundle Nursing Intervention
China120 participantsStarted 2023-01-01
Plain-language summary
This study aims to evaluate the impact of a multidisciplinary collaborative bundle nursing intervention based on targeted surveillance on the incidence of ICU device-associated infections (DAIs). The control group received routine nursing care, while the intervention group implemented a "targeted surveillance-multidisciplinary collaboration-bundle intervention" system. Infection rates, clinical outcomes, and intervention implementation were compared between the two groups.
Who can participate
Age range
18 Years – 86 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Length of ICU stay ≥48 hours
* receipt of at least one invasive device operation (urinary catheter, ventilator, or central venous catheter \[CVC\])
* age ≥18 years
* signed informed consent by the patient or family member (authorized representative for patients with impaired consciousness)
Exclusion Criteria:
* Presence of DAI at admission;
* failure to complete at least one targeted surveillance indicator record during hospitalization
* voluntary discharge or loss to follow-up after transfer
* combination of severe immunodeficiency diseases (e.g., AIDS, long-term use of immunosuppressants after organ transplantation)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
incidence of DAIs
Timeframe: from enrollment to transfer from the ICU or discharge, an average of 17 days
2
duration of antimicrobial use
Timeframe: start from using antibiotics until discontinuation or discharge, an average of about 30 days
3
length of ICU stay
Timeframe: from ICU admission to ICU transfer or discharge, an average of about 17 days
4
total length of hospital stay
Timeframe: from admission to discharge, an average of about 53 days
5
mortality
Timeframe: assessment at discharge, an average of 53 days after admission